Cite
HARVARD Citation
Wadström, H. et al. (n.d.). OP0100 Overall cancer risk in patients with rheumatoid arthritis treated with tnf inhibitors, tocilizumab, abatacept, or rituximab. Annals of the rheumatic diseases. p. 93. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wadström, H. et al. (n.d.). OP0100 Overall cancer risk in patients with rheumatoid arthritis treated with tnf inhibitors, tocilizumab, abatacept, or rituximab. Annals of the rheumatic diseases. p. 93. [Online].